The Human Insulin Analogue Aspart Is Not the Almighty Solution for Insulin Allergy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Human Insulin Analogue Aspart Is Not the Almighty Solution for Insulin Allergy

Published:2003-01-01 Issue:1 Volume:26 Page:253-254
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Takata Hiroshi¹,Kumon Yoshitaka¹,Osaki Fumiaki¹,Kumagai Chizuru¹,Arii Kaoru¹,Ikeda Yukio¹,Suehiro Tadashi¹,Hashimoto Kozo¹

Affiliation:

1. From the Second Department of Internal Medicine, Kochi Medical School, Kochi, Japan

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/26/1/253/648160/253b.pdf

Reference3 articles.

1. Ottensen JL, Nilsson P, Jami J, Weilguny D, Duhrkop M, Bucchini D, Havelund S, Fogh JM: The potential immunogenicity of human insulin and insulin analogues evaluated in transgenic mouse model. Diabetologia 37:1178–1185, 1994

2. Airaghi L, Lorini M, Tedeschi A: The insulin analog aspart: a safe alternative in insulin allergy. Diabetes Care 24:2000, 2001

3. Yasuda H, Nagata M, Moriyama H, Fujihira K, Kotani R, Yamada K, Ueda H, Yokono K: Human insulin analog insulin aspart does not cause insulin allergy. Diabetes Care 24:2008–2009, 2001

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local complications of insulin administration sites and effect on diabetes management;Journal of Clinical Nursing;2021-10-08

2. Successful management of type IV hypersensitivity reactions to human insulin analogue with injecting mixtures of biphasic insulin aspart and dexamethasone;Journal of the Formosan Medical Association;2019-04

3. Insulin aspart;Meyler's Side Effects of Drugs;2016

4. A Rare Cutaneous Complication of Insulin in a Patient With Type 2 Diabetes That Developed Foot Necrosis at the Injection Site: A Result of Inadequate Patient Education;Journal of Endocrinology and Metabolism;2014

5. Development of insulin allergy after bone marrow transplantation;Diabetic Medicine;2012-09-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3